Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 22 Dec 2023

Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC)

in Cancer Immunity and Immunotherapy

Qin Wang
Chen Qi
Jing Luo
Nan Xu
Mao-tian Xu
Yong Qiang
Chi Zhang
Yi Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1239451

3,238 views
3 citations

Review

Published on 22 Dec 2023

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas

in Cancer Immunity and Immunotherapy

Zhaoxia Li
Wei Guo
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2023.1301437

4,896 views
7 citations

Original Research

Published on 21 Dec 2023

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

in Cancer Immunity and Immunotherapy

Youlong Wang
Qi Huang
Guanqing Zhong
Jun Lv
Qinzhi Guo
Yifei Ma
Xinjia Wang
Jiling Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1191611

2,263 views

Original Research

Published on 21 Dec 2023

Utilization of cancer immunotherapy in sub-Saharan Africa

in Cancer Immunity and Immunotherapy

Elizabeth Olatunji
Saloni Patel
Katy Graef
Adedayo Joseph
Nwamaka Lasebikan
Abba Mallum
Chinelo Chigbo
Elizabeth Jaffee
Wil Ngwa

Frontiers in Oncology

doi 10.3389/fonc.2023.1266514

3,476 views
2 citations

Original Research

Published on 21 Dec 2023

Exploration of cancer associated fibroblasts phenotypes in the tumor microenvironment of classical and pleomorphic Invasive Lobular Carcinoma

in Cancer Immunity and Immunotherapy

Harsh Batra
Qingqing Ding
Renganayaki Pandurengan
Heladio Ibarguen
Neus Bota Rabassedas
Aysegul Sahin
Ignacio Wistuba
Edwin Roger Parra
Maria Gabriela Raso

Frontiers in Oncology

doi 10.3389/fonc.2023.1281650

2,925 views
3 citations

Review

Published on 20 Dec 2023

Review: therapeutic approaches for circadian modulation of the glioma microenvironment

in Cancer Immunity and Immunotherapy

Ella A. Nettnin
Thien Nguyen
Sophia Arana
Maria Isabel Barros Guinle
Cesar A. Garcia
Erin M. Gibson
Laura M. Prolo

Frontiers in Oncology

doi 10.3389/fonc.2023.1295030

3,621 views
3 citations

Case Report

Published on 15 Dec 2023

Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report

in Cancer Immunity and Immunotherapy

Yili Fan
Luyao Wang
Boxiao Chen
Jiawei Zhang
Luyu Yang
Xi Qiu
Huawei Jiang
Lei Zhu
Chao Wang
Yang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1329858

1,711 views

Original Research

Published on 13 Dec 2023

Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery

in Cancer Immunity and Immunotherapy

Xudan Wang
Weiwei Cao
Yan Qiu
Hongchen Ji
Juzheng Yuan
Weikang Wu
Fuyuan Liu
Liangyong Feng
Rui Ding
Xiao Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1174999

2,067 views
2 citations

Correction

Published on 13 Dec 2023

Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Shuqi Xie
Mengchao Wang
Chuanxiu Zeng
Yan Ou
Lu Zhao
Dong Wang
Liwei Chen
Fanming Kong
Dan Yi

Frontiers in Oncology

doi 10.3389/fonc.2023.1338060

978 views

Original Research

Published on 12 Dec 2023

Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model

in Cancer Immunity and Immunotherapy

Jie Hu
Qilong Liu
Bi Feng
Yanling Lu
Kai Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1296814

1,641 views

Systematic Review

Published on 07 Dec 2023

Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

in Cancer Immunity and Immunotherapy

Lu Ye
Fei Zhou
Dongdong Cheng
Ming Xie
Xiaoli Yan
Yuyu Xue
Qian Yang
Rong Jia
Lili Zhong
Li Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240318

5,476 views
6 citations

Original Research

Published on 07 Dec 2023

Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Justin B. Hackett
Nicholas Ramos
Stephen Barr
Madeline Bross
Nerissa T. Viola
Heather M. Gibson

Frontiers in Oncology

doi 10.3389/fonc.2023.1285117

2,926 views
1 citation

Review

Published on 06 Dec 2023

Immunogenic chemotherapy: great potential for improving response rates

in Cancer Immunity and Immunotherapy

Xiaojun Huang
Qinghuan Ren
Leixiang Yang
Di Cui
Chenyang Ma
Yueliang Zheng
Junjie Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1308681

2,782 views
11 citations

Review

Published on 05 Dec 2023

Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment

in Cancer Immunity and Immunotherapy

Liu Wenxuan
Li Liu
Lilong Zhang
Zhendong Qiu
Zhongkai Wu
Wenhong Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1323826

2,084 views
9 citations

Mini Review

Published on 04 Dec 2023

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

in Cancer Immunity and Immunotherapy

Bethan R. Hughes
Sadiq Shanaz
Seline Ismail-Sutton
Nicholas I. Wreglesworth
Christian P. Subbe
Pasquale F. Innominato

Frontiers in Oncology

doi 10.3389/fonc.2023.1284089

3,977 views
1 citation

Mini Review

Published on 01 Dec 2023

A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Robert Hsu
David J. Benjamin

Frontiers in Oncology

doi 10.3389/fonc.2023.1252652

16,497 views
5 citations